Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-23.12M
↓ 10% vs avg
Percentile
P21
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-20.95M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-23.12M | +51.5% |
| 2024 | $-47.69M | -43.5% |
| 2023 | $-33.24M | -30.6% |
| 2022 | $-25.45M | -12.1% |
| 2021 | $-22.71M | -62.3% |
| 2020 | $-14.00M | -19.4% |
| 2019 | $-11.72M | +0.9% |
| 2018 | $-11.83M | -4.0% |
| 2017 | $-11.37M | -36.1% |
| 2016 | $-8.35M | - |